The B12 Blind Spot

B12 deficiency is much more common and sneaky than most people think. While B3 often gets more attention, B12 deficiency can quietly harm your brain long before it shows up in routine blood tests, even if your lab results look "normal."

The problem, it seems, is in defining "normal". The official lab cut-off for vitamin B12 was set with an eye toward preventing anemia, not to protect the brain. New studies show that neurological damage and cognitive decline can happen even at levels still considered "fine."

Vitamin B12 is a co-factor in two crucial reactions: turning methylmalonyl‑CoA into succinyl‑CoA and converting homocysteine to methionine. When B12 is low, methylmalonic acid (MMA) and homocysteine build up, which is bad news for neurons.

Elevated MMA indicates that your cells are functionally B12-deficient, despite serum B12 looking “normal.” High homocysteine is associated with neuronal damage, impaired cell proliferation, DNA strand breaks, and cognitive decline in older adults. Ultimately, low B12 can cause paresthesias, peripheral neuropathy, de-myelination of spinal tracts, gait problems, and cognitive issues. All of these are issues that can develop long before B12 levels cross below the "normal" level.

The current guidelines for vitamin B12 deficiency are inconsistent, as there is no universal agreement on what counts as “deficient.” Many laboratories (and doctors) continue to use thresholds based exclusively on blood health rather than brain health. For example, the World Health Organization has historically recommended a deficiency cut-off around 203 pg/mL, but neurological symptoms and cognitive changes have been reported at levels higher than that. Additionally, a review of vitamin B12 and cognition highlights that labs and studies use widely different cut-offs—ranging from as low as 107 pmol/L to 350 pmol/L— These wildly different standards mean population-level analysis of B12 deficiency fluctuate range anywhere from from under 2% to over 30%.

So what do we think is a better low-end cutoff? Between 298-350 pg/mL seems most reasonable as it keeps folks above the levels that indicate neurological damage.

Regardless, all of this means it is possible to be told your B12 is “normal” while you are actually sitting in a dangerous gray zone where subtle brain and nerve problems may already be developing.

And we're not the only ones noticing it. Research confirms older adults with lower, but still “normal,” B12 levels have more white-matter damage and slower processing speed. Other studies link low B12 to faster brain volume loss. That's why it's important to use functional markers like MMA and homocysteine to reveal hidden deficiencies missed by standard tests. 

For most people, a B12 result “in range” doesn’t guarantee long-term brain health—context matters. Lower B12 levels in someone with fatigue, numbness, or cognitive symptoms should be checking MMA and homocysteine for hidden deficiency. 

To put all this bluntly: Don’t rely solely on lab “normal” ranges.  Context is key. Consider symptoms and functional markers to better protect your brain. Advocate for yourself and your loved ones. Until there is a data-driven, universally agreed upon standard, "normal" isn't good enough.


Sources:

https://ods.od.nih.gov/factsheets/VitaminB%E2%82%81%E2%82%82-HealthProfessional/

https://www.nhlbi.nih.gov/health/anemia/vitamin-b12-deficiency-anemia

https://pmc.ncbi.nlm.nih.gov/articles/PMC3875920/

https://pmc.ncbi.nlm.nih.gov/articles/PMC5836397/

https://www.bmj.com/content/385/bmj.q1019

Back to blog